Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

PHASE3CompletedINTERVENTIONAL
Enrollment

1,271

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Hypoactive Sexual Desire Disorder
Interventions
DRUG

Testosterone Transdermal System

Testosterone patch, 300 mcg/day, change patch twice a week for 52 weeks

DRUG

Placebo patch

placebo patch, changed twice a week for 52 weeks

Trial Locations (115)

10016

Research Facility, New York

19114

Research Facility, Philadelphia

20036

Research Facility, Washington D.C.

21229

Study Facility, Baltimore

23229

Study Facility, Richmond

Test Facility, Richmond

23294

Site Facility, Richmond

23452

Research Facility, Virginia Beach

23456

Research Facility, Virginia Beach

23606

Research Facility, Newport News

25301

Research Site, Charleston

27103

Site Facility, Winston-Salem

Study Facility, Winston-Salem

27609

Test Facility, Raleigh

30005

Research Facility, Alpharetta

30034

Site Facility, Decatur

30075

Site Facility, Roswell

30134

Site Facility, Douglasville

30342

Research Facility, Atlanta

31405

Test Facility, Savannah

32114

Site Facility, Daytona Beach

32207

Research Site, Jacksonville

32601

Research Facility, Gainesville

32960

Test Facility, Vero Beach

33143

Study Facility, South Miami

33156

Test Facility, Miami

33324

Research Facility, Plantation

33326

Research Facility, Weston

33409

Research Facility, West Palm Beach

33437

Research Facility, Boynton Beach

33458

Site Facility, Jupiter

33606

Research Site, Tampa

33759

Site Facility, Clearwater

33781

Research Facility, Pinellas Park

35209

Study Facility, Birmingham

35233

Research Facility, Birmingham

36116

Research Facility, Montgomery

36617

Research Facility, Mobile

37203

Research Facility, Nashville

37404

Research Facility, Chattanooga

37620

Study Facility, Bristol

39216

Research Site, Jackson

40291

Site Facility, Louisville

43212

Test Facility, Columbus

43231

Test Facility, Columbus

44106

Research Site, Cleveland

44122

Research Facility, Beachwood

Site Facility, Cleveland

45219

Research Facility, Cincinnati

45249

Study Facility, Cincinnati

45322

Test Facility, Englewood

45409

Research Facility, Dayton

45459

Test Facility, Centerville

46250

Test Facility, Indianapolis

48025

Research Facility, Bingham Farm

49079

Study Facility, Paw Paw

55435

Research Facility, Edina

59102

Site Facility, Billings

60610

Test Facility, Chicago

61820

Test Facility, Champaign

63141

Test Facility, St Louis

66202

Research Facility, Overland Park

68124

Research Site, Omaha

72223

Site Facility, Little Rock

72401

Site Facility, Jonesboro

74104

Test Facility, Tulsa

75007

Research Facility, Carrolton

75061

Research Facility, Irving

75082

Research Facility, Richardson

75231

Research Facility, Dallas

75234

Test Facility, Farmers Branch

77030

Research Facility, Houston

78229

Site Facility, San Antonio

Test Facility, San Antonio

78414

Site Facility, Corpus Christi

78705

Site Facility, Austin

79705

Research Facility, Midland

80218

Test Facility, Denver

80501

Research Facility, Longmont

83404

Study Facility, Idaho Falls

84117

Study Facility, Salt Lake City

84120

Research Facility, West Valley City

85015

Research Facility, Phoenix

85032

Research Facility, Phoenix

85225

Test Facility, Chandler

85251

Research Facility, Scottsdale

85381

Study Facility, Peoria

85712

Research Site, Tucson

85715

Research Facility, Tucson

85741

Study Facility, Tuscon

89146

Site Facility, Las Vegas

89502

Test Facility, Reno

91106

Research Facility, Pasadena

91361

Site Facility, Westlake Village

91786

Site Facility, Upland

92083

Research Facility, Vista

Site Facility, Vista

92123

Research Facility, San Diego

92260

Research Facility, Palm Desert

92805

Research Facility, Anaheim

94583

Research Facility, San Ramon

94705

Research Site, Berkeley

95405

Test Facility, Santa Rosa

97401

Site Facility, Eugene

98105

Site Facility, Seattle

98405

Research Facility, Tacoma

Test Facility, Tacoma

06320

Test Facility, New London

06708

Study Facility, Waterbury

21285-6815

Research Facility, Baltimore

02114

Study Facility, Boston

Unknown

Test Facility, Saginaw

Test Facility, Oklahoma City

08057

Test Facility, Moorestown

45267-0457

Research Facility, Cincinnati

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT00467259 - Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women | Biotech Hunter | Biotech Hunter